iQur is focussed on research and development of a universal influenza vaccine, vaccines for malaria and human cytomegalovirus infection, and a vaccine for hepatitis C.
iQur’s primary focus is the research and development of vaccines. As part of the company’s early work, iQur developed a non-invasive liver function test, the Siemens Healthcare Enhanced Liver Fibrosis (ELF) Test.
We support current users of our diagnostics wing who access ELF Test through our laboratory. The company’s primary focus is vaccine development. Existing users of ELF testing can access more information, including results, and we welcome enquiries about ELF testing.
For more on iQur research and development
For information about our work in diagnostics